Soleno Therapeutics, Inc. (SLNO) Tops Q2 EPS by 2c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q2 EPS of ($0.57), $0.02 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• SpaceX (SPCX) call put ratio 1 calls to 1.1 puts as share price at $155
• Infleqtion (INFQ) call put ratio 19 calls to 1 put with a focus on July 30 and August 20 calls as share price up 13.2%